{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T21:37:28Z","timestamp":1776980248164,"version":"3.51.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2015,6,20]],"date-time":"2015-06-20T00:00:00Z","timestamp":1434758400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1007\/s00198-015-3173-3","type":"journal-article","created":{"date-parts":[[2015,6,19]],"date-time":"2015-06-19T08:05:55Z","timestamp":1434701155000},"page":"2677-2684","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["FRAX and the effect of teriparatide on vertebral and non-vertebral fracture"],"prefix":"10.1007","volume":"26","author":[{"given":"N. C.","family":"Harvey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. A.","family":"Kanis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Od\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. T.","family":"Burge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. H.","family":"Mitlak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. V.","family":"McCloskey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,6,20]]},"reference":[{"key":"3173_CR1","doi-asserted-by":"crossref","first-page":"e5793","DOI":"10.1136\/bmj.e5793","volume":"346","author":"AD Hingorani","year":"2013","unstructured":"Hingorani AD, Windt DA, Riley RD et al (2013) PROGRESS group. Prognosis research strategy (PROGRESS) 4: stratified medicine research. BMJ 346:e5793. doi: 10.1136\/bmj.e5793","journal-title":"BMJ"},{"key":"3173_CR2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00198-012-2074-y","volume":"24","author":"JA Kanis","year":"2013","unstructured":"Kanis JA, McCloskey EV, Johansson H, Cooper C, Rizzoli R, Reginster J-Y on behalf of the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF) (2013) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 24:23\u201357","journal-title":"Osteoporos Int"},{"key":"3173_CR3","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","volume":"344","author":"RM Neer","year":"2001","unstructured":"Neer RM, Arnaud CD, Zanchetta JR et al (2001) Effect of parathyroid hormone (1\u201334) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434\u20131441","journal-title":"N Engl J Med"},{"key":"3173_CR4","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1359\/JBMR.050501","volume":"20","author":"R Prince","year":"2005","unstructured":"Prince R, Sipos A, Hossain A et al (2005) Sustained non vertebral fragility fracture risk reduction after discontinuation of teriparatide treatment. J Bone Miner Res 20:1507\u20131513","journal-title":"J Bone Miner Res"},{"key":"3173_CR5","volume-title":"Assessment of osteoporosis at the primary health-care level. Technical Report","author":"Kanis JA on behalf of the World Health Organization Scientific Group","year":"2008","unstructured":"Kanis JA on behalf of the World Health Organization Scientific Group (2008) Assessment of osteoporosis at the primary health-care level. Technical Report. WHO Collaborating Centre, University of Sheffield, UK"},{"key":"3173_CR6","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00198-007-0543-5","volume":"19","author":"JA Kanis","year":"2008","unstructured":"Kanis JA, Johnell O, Oden A, Johansson H, McCloskey EV (2008) FRAX\u2122 and the assessment of fracture probability in men and women from the UK. Osteoporos Int 19:385\u2013397","journal-title":"Osteoporos Int"},{"key":"3173_CR7","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1359\/jbmr.061008","volume":"22","author":"EV McCloskey","year":"2007","unstructured":"McCloskey EV, Beneton M, Charlesworth D et al (2007) Clodronate reduces the incidence of fractures in community dwelling elderly women unselected for osteoporosis: results of a double-blind, placebo-controlled randomized study. J Bone Miner Res 22:135\u2013141","journal-title":"J Bone Miner Res"},{"key":"3173_CR8","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00198-008-0786-9","volume":"20","author":"EV McCloskey","year":"2009","unstructured":"McCloskey EV, Johansson H, Oden A et al (2009) Ten-year fracture probability identifies women who will benefit from clodronate therapy\u2014additional results from a double blind, placebo controlled randomised study. Osteoporos Int 20:811\u2013818","journal-title":"Osteoporos Int"},{"key":"3173_CR9","first-page":"49","volume":"44","author":"JA Kanis","year":"2009","unstructured":"Kanis JA, Johansson H, Od\u00e9n A, McCloskey EV (2009) Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX\u00ae. Bone 44:49\u201354","journal-title":"Bone"},{"issue":"7","key":"3173_CR10","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1002\/jbmr.1606","volume":"27","author":"EV McCloskey","year":"2012","unstructured":"McCloskey EV, Johansson H, Od\u00e9n A et al (2012) Denosumab reduces the risk of all osteoporotic fractures in postmenopausal women, particularly in those with moderate to high fracture risk as assessed with FRAX\u00ae. J Bone Miner Res 27(7):1480\u20131486","journal-title":"J Bone Miner Res"},{"key":"3173_CR11","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.bone.2010.06.009","volume":"47","author":"JA Kanis","year":"2010","unstructured":"Kanis JA, Johansson H, Od\u00e9n A et al (2010) A meta-analysis of the efficacy of raloxifene on all clinical and vertebral fractures and its dependency on FRAX. Bone 47:729\u2013735","journal-title":"Bone"},{"key":"3173_CR12","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1007\/s00198-010-1474-0","volume":"22","author":"JA Kanis","year":"2011","unstructured":"Kanis JA, J\u00f6nsson B, Od\u00e9n A, McCloskey EV (2011) A meta-analysis of the effect of strontium ranelate on the risk of vertebral and non-vertebral fracture in postmenopausal osteoporosis and the interaction with FRAX\u00ae. Osteoporos Int 22:2347\u20132355, with erratum Osteoporos Int. 22:2357\u20132358","journal-title":"Osteoporos Int"},{"key":"3173_CR13","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/jbmr.5650080915","volume":"8","author":"HK Genant","year":"1993","unstructured":"Genant HK, Wu CY, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:1137\u20131148","journal-title":"J Bone Miner Res"},{"key":"3173_CR14","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/jbmr.5650110716","volume":"11","author":"HK Genant","year":"1996","unstructured":"Genant HK, Jergas M, Palermo L et al (1996) Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis. J Bone Miner Res 11:984\u2013996","journal-title":"J Bone Miner Res"},{"key":"3173_CR15","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00198-013-2460-0","volume":"25","author":"H Johansson","year":"2014","unstructured":"Johansson H, Od\u00e9n A, McCloskey EV, Kanis JA (2014) Mild morphometric vertebral fractures predict vertebral fractures but not non-vertebral fractures. Osteoporos Int 25:235\u2013241","journal-title":"Osteoporos Int"},{"key":"3173_CR16","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s001980170087","volume":"12","author":"Y Lu","year":"2001","unstructured":"Lu Y, Fuerst T, Hui S, Genant HK (2001) Standardization of bone mineral density at femoral neck, trochanter and Ward's triangle. Osteoporos Int 12:438\u2013444","journal-title":"Osteoporos Int"},{"key":"3173_CR17","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s001980050093","volume":"8","author":"AC Looker","year":"1998","unstructured":"Looker AC, Wahner HW, Dunn WL et al (1998) Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int 8:468\u2013489","journal-title":"Osteoporos Int"},{"key":"3173_CR18","first-page":"131","volume-title":"Statistical methods in cancer research volume II","author":"NE Breslow","year":"1987","unstructured":"Breslow NE, Day NE (1987) Statistical methods in cancer research volume II. IARC Scientific Publications No 32, Lyon, pp 131\u2013135"},{"key":"3173_CR19","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00198-013-2521-4","volume":"25","author":"K Kim","year":"2014","unstructured":"Kim K, Svedbom A, Luo X, Sutradhar S, Kanis JA (2014) Comparative cost-effectiveness of bazedoxifene and raloxifene in the treatment of postmenopausal osteoporosis in Europe using the FRAX algorithm. Osteoporos Int 25:325\u2013337","journal-title":"Osteoporos Int"},{"issue":"4","key":"3173_CR20","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00774-013-0505-2","volume":"32","author":"T Nakano","year":"2014","unstructured":"Nakano T, Shiraki M, Sugimoto T et al (2014) Once-weekly teriparatide reduces the risk of vertebral fracture in patients with various fracture risks: subgroup analysis of the Teriparatide Once-Weekly Efficacy Research (TOWER) trial. J Bone Miner Metab 32(4):441\u2013446","journal-title":"J Bone Miner Metab"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-015-3173-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-015-3173-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-015-3173-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T15:15:23Z","timestamp":1558624523000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-015-3173-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,20]]},"references-count":20,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["3173"],"URL":"https:\/\/doi.org\/10.1007\/s00198-015-3173-3","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,20]]}}}